Saama Technologies has partnered with Oracle to offer life sciences industry artificial intelligence (AI) enabled applications to accelerate clinical trials.
Pharmaceutical research and development expert with decades of experience Industry visionary with deep knowledge of global regulatory processes and practices 7-member board will continue its focus on advancing and growing the company
Saama and iNDX.Ai Launch New COVID-19 Command Center Analytics Platform To Expedite Clinical Research Efforts by Individual Sponsors
Campbell, CA (May 5, 2020) – Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, and iNDX.Ai, a leading Multi-omics Data Analytics and translational research platform company, today announced the launch of the new COVID-19 Command Center. The COVID-19 Command Center, based on a combination of Saama’s Life Science Analytics Cloud (LSAC) and iNDX.Ai’s iCore Platform, is a purpose-built, therapeutic area-specific data analytics platform that will accelerate the ability of life sciences companies to expedite internal research and development programs for therapies to prevent and treat COVID-19.
Saama Makes State-of-the-Art Clinical Analytics Platform Available to Integrate Data from all Organizations Investigating COVID-19 Treatments
Open Invitation Issued to Corporate and Government Organizations to Mitigate Pandemic
Saama’s Growth Strategy Continues with Addition of Jonathan Burr and Gregory Simpson to Leadership Team
Campbell, CA (February 18, 2020) - Saama Technologies, Inc. (“Saama”), the number one AI clinical analytics platform company, announced today that it recently expanded its leadership team to include life science technology expert Jonathan Burr as Senior Vice President of Clinical Platform Strategy, and technology marketing leader Gregory T. Simpson as Vice President, Head of Marketing. Jonathan is responsible for growing client adoption of Saama’s existing products, and Greg is charged with building and strengthening the Saama brand. The announcement came at the start of the 11th Annual Summit for Clinical Ops Executives (SCOPE) meeting in Orlando.
Campbell, CA (February 18, 2020) - Saama Technologies, Inc., the number one AI clinical analytics platform company, announced today that it signed an agreement with Pfizer Inc. to develop and deploy an AI-powered analytics solution to reduce the challenges commonly experienced by clinical study data managers and monitors. Under this agreement, Saama’s award-winning Life Science Analytics Cloud (LSAC) platform will aggregate, transform, analyze, model and predict clinical data queries using deep learning techniques. Pfizer will provide the required ground truth clinical data and domain expertise to train Saama models to achieve the required accuracy.
Transaction Creates Expanded Portfolio of Cloud-Based Capabilities to Advance Clinical Development
Campbell, CA (February 19, 2019) - Saama Technologies, Inc., a leading data analytics company, today unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud (LSAC). Saama announced the addition of these state-of-the-art programs infused with artificial intelligence (AI) -- Virtual Assistant/AI, Operational and Financial Risk Mitigation, and Drug Efficacy and Patient Safety Analytics -- during the 10th Annual Summit for Clinical Ops Executives (SCOPE) in Orlando.
Saama Technologies And Icon Commercialization And Outcomes Partner To Unlock The Value Of Real World Evidence (RWE)
Campbell, CA (May 15, 2018) – Saama Technologies, a leading clinical and health data analytics company, and ICON plc(NASDAQ: ICLR), a global provider of drug development and commercialization solutions and services, have partnered to accelerate the use of Real World Evidence (RWE) across the product lifecycle and drive mission critical decisions for medical affairs, reimbursement and commercialization functions.
Saama Expands Leadership Team With Addition Of Visionary Medical Affairs Expert Kenneth L. Massey, Pharm.D.
CAMPBELL, CA (April 02, 2018)— Saama Technologies, Inc., a leading clinical data analytics company, today announced that Kenneth L. Massey, Pharm.D., one of the foremost medical affairs professionals in the life sciences industry, has joined the company in the key position of Chief Life Sciences Officer. Ken brings 30 years of medical affairs and drug development experience at leading global pharmaceutical companies to his new role at Saama.
Elligo Health Research And Saama Technologies Announce Strategic Partnership To Advance Clinical Research Data Management
AUSTIN, TX & CAMPBELL, CA (February 28, 2018) – Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, is partnering with Saama Technologies, Inc., a leading clinical data analytics company, to improve awareness of, access to, and participation in clinical trials for U.S. physicians and patients.
Informa Pharma Intelligence’s Citeline Api Works With Saama To Deliver Unprecedented Insight Into Clinical Trials
London (February 12, 2018) – Today, Citeline, part of Informa Pharma Intelligence’s suite of pharmaceutical, medtech and biomedical research and analysis solutions, and Saama Technologies, Inc., a leading clinical analytics company, announced a partnership to integrate Citeline’s application programming interfaces (APIs) with Saama’s artificial intelligence and deep learning solutions.
Saama Technologies Earns Frost & Sullivan’s Recognition As A Technology Leader, With Its Real-world Evidence IT Solutions
Santa Clara, CA (February 12, 2018) – Based on its recent analysis of the real-world evidence (RWE) IT solutions market, Frost & Sullivan recognizes Saama Technologies (Saama) with the 2018 Global Enabling Technology Leadership Award for its fluid analytics platform, a set of cloud-enabled Big Data management and analytics solutions that support clients’ needs to simultaneously organize, process and translate unstructured, semi-structured, and structured data, especially in the pharmaceutical and biotechnology clinical trial and drug discovery segments.
Saama Receives Two Awards At 2018 Big Data & Analytics Converge For Innovation And Industry Excellence
Campbell, CA (February 4, 2018) – Saama Technologies, Inc., a leading clinical analytics company, has received not one, but two awards at the Big Data & Analytics Converge 2018. The company received the “Innovative Technology of the Year” award as well as the “Excellence in Industry Application” award in the B2B Sector.
CAMPBELL, CA (December 18, 2017) – PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Saama’s Life Science Analytics Cloud as one of the most innovative Products of 2017.
CAMPBELL, CA (October 16, 2017) – Saama Technologies, Inc., a leading clinical analytics company, has opened a new office in Bridgewater, New Jersey. This new office space brings the company closer to its current and prospective clients, who are a part of a thriving pharmaceutical and biotechnology hub.
CAMPBELL, CA (September 19, 2017) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced the launch of its Life Science Analytics Cloud, which is designed to optimize clinical development processes and deliver outcomes by streamlining the steps of the entire clinical data journey. The suite offers a complete range of cloud-based clinical data analytics solutions for the Life Sciences industry.
CAMPBELL, CA (August 07, 2017) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, announced that Christine Poon, a life sciences industry luminary, is going to be a member of their Board of Advisors.
CAMPBELL, CA (August 01, 2017) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced the addition of information technology icon, John Hinshaw to its Board of Advisors.
CAMPBELL, CA (June 8, 2017) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced that industry luminary Rebecca Daniels Kush, Ph.D., has joined its Board of Advisors.